Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling01:40

Bone Remodeling

38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Bone Disorders01:29

Bone Disorders

3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

3.4K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.4K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

4.6K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study.

Cancer communications (London, England)·2026
Same author

First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.

JAMA oncology·2026
Same author

A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same author

Dual effects of soil conditioners on wheat yield and soil properties in southern henan.

Scientific reports·2026
Same author

Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.

Future oncology (London, England)·2026
Same author

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.

Lancet (London, England)·2026
Same journal

Lactoferrin improves scopolamine-induced memory impairment in mice.

Drug discoveries & therapeutics·2026
Same journal

Are we ready to replace animal models? A perspective on regulatory challenges of human-relevant drug testing systems.

Drug discoveries & therapeutics·2026
Same journal

Associations between wound exudate amino acid profiles and microbial dissimilarity in wound and peri-wound skin in healing wounds.

Drug discoveries & therapeutics·2026
Same journal

Exploratory study on the effect of ferulic acid derived from rice bran on dull skin.

Drug discoveries & therapeutics·2026
Same journal

Seasonality of psychiatric symptoms in older adults in long-term psychiatric care.

Drug discoveries & therapeutics·2026
Same journal

Docosahexaenoic acid increases tyrosine hydroxylase phosphorylation at Ser40 without increasing tyrosine hydroxylase protein expression in differentiated NG108-15 cells.

Drug discoveries & therapeutics·2026
See all related articles

Related Experiment Video

Updated: Jul 19, 2025

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
09:20

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

7.1K

Apolipoprotein E deficiency attenuated osteogenesis via down-regulating osterix.

Qing Qi1,2,3, Yingping Xu4, Hongmei Sun1,2,3

  • 1Laboratory for Reproductive Immunology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Drug Discoveries & Therapeutics
|August 16, 2023
PubMed
Summary
This summary is machine-generated.

Apolipoprotein E (ApoE) deficiency worsens bone loss in mice, impairing osteoblast function and bone formation by reducing osterix expression. This highlights ApoE's crucial role in maintaining bone health.

Keywords:
apolipoprotein Eosteoblastosteogenesisosterix

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.7K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

936

Related Experiment Videos

Last Updated: Jul 19, 2025

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
09:20

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis

Published on: December 18, 2019

7.1K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

11.7K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

936

Area of Science:

  • Bone biology
  • Endocrinology
  • Molecular genetics

Background:

  • Apolipoprotein E (ApoE) is involved in osteogenesis and osteoblast function, but its precise mechanisms remain unclear.
  • Estrogen deficiency, as seen in post-menopausal osteoporosis, significantly impacts bone health.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of ApoE in bone formation.
  • To determine the effect of ApoE deficiency on osteoporotic bone loss.

Main Methods:

  • Ovariectomy-induced osteoporosis model in ApoE knockout (ApoE-/-) and wild-type (WT) mice.
  • Assessment of bone quality via bone mineral density and histomorphometry.
  • In vitro culture of primary osteoblasts from ApoE-/- and WT mice to analyze differentiation markers.

Main Results:

  • ApoE-/- mice showed exacerbated bone loss after ovariectomy compared to WT mice.
  • ApoE deficiency reduced osteoblast activity and osteogenesis, evidenced by decreased osterix expression.
  • Osteoprotegerin expression was lower in ApoE-/- osteoblasts, while collagen-1 expression remained unaffected.

Conclusions:

  • ApoE deficiency contributes to bone loss and impaired osteogenesis.
  • Down-regulation of osterix expression is a key mechanism by which ApoE deficiency affects bone formation.